Literature DB >> 3459717

Expression of protooncogenes in murine osteosarcomas.

A Schön, L Michiels, M Janowski, J Merregaert, V Erfle.   

Abstract

The expression of 7 protooncogenes (c-sis, c-abl, c-mos, c-bas, c-Ki-ras, c-fos, c-myc) was examined in transplants and established cell lines from spontaneous and radiation-induced murine osteosarcomas. The transplant tumors were compared with different tissues, particularly skeletal tissue (sternum), and the osteosarcoma cell lines with fibroblast lines from the same mouse strains. C-sis was expressed above the level of controls in 2 osteosarcomas (TV, Os5). Three osteosarcomas showed over-expression of c-abl (TVK, DOS, Os5), c-bas (DOS, Os5 and V893) and c-fos (TVK, DOS, Os5), and 4 osteosarcomas showed over-expression of c-Ki-ras (TVK, DOS, Os5, Os16) and c-myc (TVK, DOS, TV, Os5). C-mos expression was not observed under the conditions used. One cell line (Os5) showed an altered transcript (1 kb transcript of c-fos). Apart from the relatively frequent increase in expression of the c-myc and c-ras-family, there was no indication that any particular protooncogene or combination of protooncogenes was associated with murine osteosarcomas.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3459717     DOI: 10.1002/ijc.2910380112

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  9 in total

1.  Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis.

Authors:  D P Satijn; D J Olson; J van der Vlag; K M Hamer; C Lambrechts; H Masselink; M J Gunster; R G Sewalt; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

2.  Osteosarcomas in transgenic mice expressing an alpha-amylase-SV40 T-antigen hybrid gene.

Authors:  B B Knowles; J McCarrick; N Fox; D Solter; I Damjanov
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

3.  Osteosarcomagenesis: modeling cancer initiation in the mouse.

Authors:  Kevin B Jones
Journal:  Sarcoma       Date:  2011-02-20

4.  c-fos expression precedes osteogenic differentiation of cartilage cells in vitro.

Authors:  E I Closs; A B Murray; J Schmidt; A Schön; V Erfle; P G Strauss
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

5.  Genetically engineered mouse models and human osteosarcoma.

Authors:  Alvin Jm Ng; Anthony J Mutsaers; Emma K Baker; Carl R Walkley
Journal:  Clin Sarcoma Res       Date:  2012-10-04

Review 6.  Oncogenes and radiation carcinogenesis.

Authors:  S J Garte; F J Burns
Journal:  Environ Health Perspect       Date:  1991-06       Impact factor: 9.031

7.  Inactivation of p53 gene in human and murine osteosarcoma cells.

Authors:  N Chandar; B Billig; J McMaster; J Novak
Journal:  Br J Cancer       Date:  1992-02       Impact factor: 7.640

8.  Osteoblasts are target cells for transformation in c-fos transgenic mice.

Authors:  A E Grigoriadis; K Schellander; Z Q Wang; E F Wagner
Journal:  J Cell Biol       Date:  1993-08       Impact factor: 10.539

9.  c-Fos induces chondrogenic tumor formation in immortalized human mesenchymal progenitor cells.

Authors:  Ander Abarrategi; Stefano Gambera; Arantzazu Alfranca; Miguel A Rodriguez-Milla; Raquel Perez-Tavarez; Kevin Rouault-Pierre; Alexander Waclawiczek; Probir Chakravarty; Francisca Mulero; César Trigueros; Samuel Navarro; Dominique Bonnet; Javier García-Castro
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.